Bispecific Molecules in Oncology: Analytical Tool

NEW YORK, Oct. 4, 2018 /PRNewswire/ — Bispecific molecules carry huge treatment potential within cancer immunotherapy. In broad strokes this therapeutic category can be divided into three classes: (I) cytotoxic effector cell redirectors/CTL response; (II) tumor-targeted immunomodulators; and (II) dual immunomodulators. Read the full report: https://www.reportlinker.com/p05576157 Bispecific Molecules in […]

Leave a Reply